CSL Ltd (CSL)

296.64
+1.43(+0.48%)
  • Volume:
    403,912
  • Bid/Ask:
    295.11/297.00
  • Day's Range:
    294.15 - 297.73

CSL Overview

Prev. Close
295.21
Day's Range
294.15-297.73
Revenue
13.06B
Open
296.51
52 wk Range
242-320.42
EPS
7.53
Volume
403,912
Market Cap
134.96B
Dividend (Yield)
1.35
(0.95%)
Average Volume (3m)
655,156
P/E Ratio
39.41
Beta
0.43
1-Year Change
4.33%
Shares Outstanding
454,974,366
Next Earnings Date
18 Aug 2021
What is your sentiment on CSL Ltd?
or
Market is currently closed. Voting is open during market hours.

CSL Ltd News

CSL Ltd Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyStrong BuyStrong Buy
Technical IndicatorsSellSellStrong BuyStrong BuyBuy
SummarySellNeutralStrong BuyStrong BuyStrong Buy

CSL Ltd Company Profile

CSL Ltd Company Profile

Employees
27000
Market
Australia

CSL Limited is an Australia-based biotechnology company engaged in the developing and delivering medicines that treat people with rare diseases. It offers treatments for people who are living with conditions in the immunology and neurology; haematology and thrombosis; cardiovascular and metabolic; respiratory, and transplant therapeutic areas. Its segment includes CSL Behring and Seqirus. CSL Behring segment manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus segment manufactures and distributes non-plasma biotherapeutic products and develops influenza related products.

Read More
  • do I buy
    0
    • It can only fall so much
      0
      • Anyone knows why CSL keep dropping??
        3
        • Great! BTFD 👍🏻
          0
        • Not as strong forecasts for future earnings
          0
        • Most business in US so profits less as US dollar taking a hit, alot of the work they do has stopped since covid.
          2
      • As of 27/0220 CSL is going up after a temporary fall. Rather its an opputunity to stock up and avoid regrets. Plus exdividend next month. Have fun fellow traders and investers.
        8
        • It will go up to at least 220 ; T2: 232
          0
          • looks like it's on a downtrend when checking yearly monthly charts, I'd be looking for some pretty solid bullish reversal indicators before considering
            3
            • looks like it's on a downtrend when checking yearly monthly charts, I'd be looking for some pretty solid bullish reversal indicators before considering
              0
              • invest later when they are at their lowest
                0
                • is this good to invest in ?
                  1
                  • Do some research and you might find out.
                    1
                • is this good to invest in ?
                  1
                  • invest later when they are at their lowest
                    0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.